Addressing the "What do we have to lose? Just give the drug" rationale: making the case for clinical trials and against off-label use in COVID-19

被引：1

作者：

Ramnath, Venktesh R. ^{[1
]}

Zar, Heather J. ^{[2
,3
,4
]}

Malhotra, Atul ^{[1
]}

机构：

[1] UC San Diego Hlth, Div Pulm Crit Care & Sleep Med, La Jolla, CA 92037 USA

[2] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa

[3] Univ Cape Town, SA MRC Unit Child & Adolescent Hlth, Cape Town, South Africa

[4] Red Cross War Mem Childrens Hosp, Cape Town, South Africa

来源：

JOURNAL OF THORACIC DISEASE | 2020年 / 12卷 / 06期

关键词：

CONVALESCENT PLASMA; MEDICINE; CARE;

D O I：

10.21037/jtd-20-2011

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：3031 / 3034

页数：4

共 44 条

[1] Multiple drugsPancytopenia, COVID-19 and off-label use: case report
[J]. Reactions Weekly, 2020, 1831 (1) : 209 - 209
[2] Dexamethasone/rituximabWorsening of COVID-19 pneumonia and off-label use: case report
[J]. Reactions Weekly, 2022, 1929 (1) : 248 - 248
[3] Multiple drugsLack of efficacy and off-label use in COVID-19: case report
[J]. Reactions Weekly, 2022, 1914 (1) : 317 - 317
[4] COVID-19 vaccine/rituximabLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1943 (1) : 237 - 237
[5] Multiple drugsProlongation of COVID-19, lack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1946 (1) : 399 - 399
[6] UDCA treatment against COVID-19: Do we have enough clinical evidence for drug repurposing?
Ojeda-Fernandez, Luisa
Baviera, Marta
Macaluso, Giulia
Schena, Simone
Tettamanti, Mauro
Cartabia, Massimo
Foresta, Andreana
Manucci, Pier Manuccio
Nobili, Alessandro
Remuzzi, Giuseppe
Roncaglioni, Carla
[J]. JOURNAL OF INTERNAL MEDICINE, 2024, 295 (01) : 110 - 112
[7] Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation
Belayneh, Anteneh
[J]. RESEARCH AND REPORTS IN TROPICAL MEDICINE, 2020, 11 : 61 - 72
[8] Multiple drugsProlonged COVID-19 Infection, lack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1929 (1) : 473 - 473
[9] PrednisoneRebound effect manifesting as worsening of COVID-19 following off-label use: case report
[J]. Reactions Weekly, 2023, 1938 (1) : 1103 - 1103
[10] Azithromycin/hydroxychloroquineVentricular arrhythmias following off-label use in COVID-19: 2 case reports
[J]. Reactions Weekly, 2020, 1819 (1) : 61 - 61

← 1 2 3 4 5 →